159 related articles for article (PubMed ID: 11451163)
1. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
Fernandez M; Lambrecht RW; Bonkovsky HL
J Hepatol; 2001 Jun; 34(6):812-7. PubMed ID: 11451163
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
3. Effects of Nuclear Factor-E2-related factor 2/Heme Oxygenase 1 on splanchnic hemodynamics in experimental cirrhosis with portal hypertension.
Qin J; He Y; Duan M; Luo M
Microvasc Res; 2017 May; 111():12-19. PubMed ID: 28025064
[TBL] [Abstract][Full Text] [Related]
4. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Heinemann A; Stauber RE
J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
[TBL] [Abstract][Full Text] [Related]
5. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
6. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats.
Fernandez M; Bonkovsky HL
Hepatology; 1999 Jun; 29(6):1672-9. PubMed ID: 10347107
[TBL] [Abstract][Full Text] [Related]
7. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R; Shah V; Sessa WC; Groszmann RJ
Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
[TBL] [Abstract][Full Text] [Related]
8. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats.
Heinemann A; Stauber RE
Eur J Pharmacol; 1995 May; 278(1):87-90. PubMed ID: 7545125
[TBL] [Abstract][Full Text] [Related]
9. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Luo B; Tang L; Ryter SW; Stockard CR; Grizzle WE; Fallon MB
Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
[TBL] [Abstract][Full Text] [Related]
10. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.
Sieber CC; Lee FY; Groszmann RJ
Hepatology; 1996 May; 23(5):1218-23. PubMed ID: 8621156
[TBL] [Abstract][Full Text] [Related]
11. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
12. Role of heme oxygenase/carbon monoxide pathway on the vascular response to noradrenaline in portal hypertensive rats.
Erario MA; Gonzales S; Romay S; Eizayaga FX; Castro JL; Lemberg A; Tomaro ML
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):196-201. PubMed ID: 15743403
[TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
14. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
Casadevall M; Piqué JM; Cirera I; Goldin E; Elizalde I; Panés J; Martínez-Cuesta MA; Bosch J; Terés J; Rodés J
Gastroenterology; 1996 Apr; 110(4):1156-65. PubMed ID: 8613005
[TBL] [Abstract][Full Text] [Related]
15. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats.
Gadano AC; Sogni P; Yang S; Cailmail S; Moreau R; Nepveux P; Couturier D; Lebrec D
J Hepatol; 1997 Mar; 26(3):678-86. PubMed ID: 9075677
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.
Shah V; Wiest R; Garcia-Cardena G; Cadelina G; Groszmann RJ; Sessa WC
Am J Physiol; 1999 Aug; 277(2):G463-8. PubMed ID: 10444461
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.
Angermayr B; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J; Fernandez M
J Hepatol; 2006 Jun; 44(6):1033-9. PubMed ID: 16458992
[TBL] [Abstract][Full Text] [Related]
18. Enhanced G-protein-induced relaxation in portal hypertensive rats: role of nitric oxide.
Hou MC; Cahill PA; Zhang S; Redmond EM; Sitzmann JV
Hepatology; 1997 Jul; 26(1):27-33. PubMed ID: 9214448
[TBL] [Abstract][Full Text] [Related]
19. iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
Kajita M; Murata T; Horiguchi K; Iizuka M; Hori M; Ozaki H
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1021-31. PubMed ID: 21193589
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
